Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Epidemiology > Exam 4 Topics > Flashcards

Exam 4 Topics Flashcards

1
Q

What is a primary study?

A

Collection of original data

Ex: Cross-sectional, RCT’s, cohort studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a secondary study?

A

Review and analysis of previous studies

Ex: Meta-analysis, Systemic Reviews

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A study in which the investigators publishes clinical trial results utilizing the collection of original data is an example of what kind of study?

A

Primary Study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A Meta-analysis is an example of what kind of study?

A

Secondary study because it reviews and analyzes previously collected data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is primary prevention?

A

Prevent development of disease

Ex: lower risk factors of CHD in those without apparent disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is secondary prevention?

A

Early identification and treatment to reduce complications and disease progression

Ex: risk factor reduction in those with CHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is tertiary prevention?

A

Rehabilitation/functional restoration of those with end organ damage, as well as reduction in risk factors for disease progression

Ex: Cardiac rehabilitation for CHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is efficacy?

A

Does the Rx work under ideal, “laboratory” conditions?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is efficacy?

A

Does Rx work in “real-life” situations?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between efficacy and effectiveness?

A

Efficacy can be defined as the performance of an intervention under ideal and controlled circumstances, whereas effectiveness refers to its performance under ‘real-world’ conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is efficiency?

A

It may be effective, but is it worth it?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the problem with non-randomized designs?

A

Increased opportunity for self-selection

*Need to be cautious in interpreting cause and effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Phase I studies?

A

Small (20-80 subjects) clinical pharmacologic studies focusing on safety, dosage ranges and toxic effects

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are Phase II studies?

A

Clinical investigations of 100-300 subjects for safety and efficacy —> refinement and extension of phase I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Phase III studies?

A

RCT’s may have hundreds or thousands of subjects recruited from many locations. Focus moves towards effectiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are Phase IV studies?

A

Long-term safety, adherence, packaging (combined pills)

Generally non-randomized, Effectiveness

17
Q

What is the number needed to treat (NNT)?

A

Is the number of patients you need to treat to prevent one additional bad outcome (death, stroke, etc.)

18
Q

What is the equation to calculate the number needed to treat (NNT)?

A

NNT = 1/ARR

ARR = Absolute Risk Reduction

19
Q

What is the number needed to harm (NNH)?

A

Is the number of patients you have to treat before you can expect at least one to have an adverse outcome or side effect

20
Q

In general, you want a ______ NNT and _______ NNH if possible.

A

Low, High

21
Q

True or False: Randomized Trials are considered the ideal design for evaluating both the effectiveness and the side effects of new forms of interventions.

A

True

22
Q

What are historical controls?

A

Comparison groups from the past, where we go back to the records of the patient with the same disease who were treated before the new therapy was created.

Useful if the disease is uniformly fatal and new treatment is available, where environmental factors need to be ruled out.

23
Q

Lower rates of vaccines not only leave vulnerable individuals at risk, but also affect ________________

A

Herd Immunity

24
Q

What is Herd Immunity?

A

Resistance of a group of people to an attack by a disease to which a large proportion of the members of the group are immune

Assumes that immunity from vaccine or infection is lasting

25
Q

What levels of prevention fall under the public health sector?

A

Primary Prevention, and a small bit of some secondary prevention

26
Q

What levels of prevention fall under primary care?

A

Primary, secondary, and tertiary prevention

27
Q

What levels of prevention fall under speciality care?

A

Tertiary prevention along with some secondary prevention techniques

28
Q

Health education programs have what level of impact on individuals?

A

Minimal impact on individual freedoms

29
Q

What is the purpose of health screenings?

A

Early detection and treatments

*minimal impact on individual freedoms to participate

30
Q

Regulations have what level of impact on individual’s?

A

Significant impact on individual freedoms

31
Q

What kinds of bias’ can arise when an investigator is assessing their own program?

A

conscious and subconscious biases

32
Q

Define “process” measure

A

We decide what constitutes the components of good care

Cons:
- Expert panel recommendations change over time (for example placing neonates on 100% oxygen)
- Don’t ensure that the patient is benefiting (measuring patients blood pressure at each visit)

33
Q

What is efficacy?

A

Does the agent or intervention work under ideal laboratory conditions (controlled environment such as an RCT for a new medication)

34
Q

What is effectiveness?

A

How well does the agent or intervention work in real-life

For example, if a medication was found to be efficacious in clinical trials but tastes horribly the public won’t take it and benefit

35
Q

What is efficiency?

A

If the agent is found to be effective, what is the cost benefit ratio

Cost includes not only money, but also discomfort, pain, absenteesim, disability, and social stigma

36
Q

What is the equation for NNH?

A

NNH = 1/ARI (absolute risk increase)

37
Q

What are the typical research designs in the evaluation of health care services?

A

Randomized Control Trial
Non-randomized trails
Historical Control

38
Q

Outline common errors made in the interpretation of research evaluating health care services?

A
  • Self selection if not an RCT
  • Historical controls assume nothing else changes
  • Patient condition/severity
  • Are characteristics of the group comparable? What about methods?
39
Q

What are some health care service outcome endpoints?

A

M&M, QOL, functional status, patient perceptions on health status

Epidemiology (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions